Global Dialysis Market Report by Type (Hemodialysis, Peritoneal dialysis), Product & Services (Services, Equipment, Consumables, Drugs), End-Users (In-center dialysis, Home dialysis), Region and Company Analysis 2023-2028

Global Dialysis Market Outlook

Global Dialysis Market size is projected to surpass round US$ 141.26 Billion by 2028, in line with Renub Research. Dialysis is a treatment used to take away waste merchandise from the blood, which includes urea and creatinine, resulting from defective kidney feature, and is often essential for people stricken by chronic renal failure. End-level renal disease (ESRD) and kidney transplantation both of them are handled with dialysis treatment. Throughout the procedure, the blood is wiped clean, extra fluid and toxins are removed, and electrolyte balance is restored.The increasing prevalence of hypertension and diabetes in global populace is surging the risk of growing kidney disease and kidney failure worldwide.

Chronic kidney sickness is a modern situation that impacts >10% of the general populace internationally, amounting to >800 million individuals. In 2021, the expected global prevalence of diabetes amongst human beings 20–79 years of age became 11%, which is predicted to grow to 12% via 2045. More than 1 in 7 US adults–about 35.5 million human beings or 14% are expected to have CKD. For instance, in line with the 2022 statistics published by the International Diabetes Federation inside the 10thedition of 2021, in Spain, 5,141.3 thousand people are living with diabetes, in 2021. In addition, as in step with the equal supply, this range is projected to reach 5.58 Million via 2030 and 5.65 Million by 2050. Also, with the same source, in 2021, 6.20 Million people are living with diabetes in Germany. In addition, as per the identical supply, this wide variety is projected to attain 6.52 Million by 2030. CKD is common in people aged 65 years or older (34%) than in human’s elderly 45–64 years (12%) or 18–44 years (6%) in the United States.

Global Dialysis Companies News

Baxter International Inc.

Jan 2023, Baxter International Inc. announced a strategic plan to enhance operational effectiveness, accelerate innovation, and create more value for stakeholders. The plan includes:

• Spinning off Renal Care and Acute Therapies GBUs into an independent, publicly traded company.
• Streamlining commercial and manufacturing operations.

November 2023, Baxter's Share source RPM platform combined with automated PD reduces the risk of PD technique failure by 77%, lowering the need for in-center dialysis. Theranova dialyzer's HDx therapy reduces annual water consumption by 27%, lowers electricity usage by 17%, and cuts costs vs. online HDF.

Fresenius Medical Care

In Oct 2023, Fresenius Medical Care introduced a predictive model utilizing machine learning and cloud computing. This innovative approach aids in early detection of life-threatening complications among kidney dialysis patients, facilitating proactive intervention to ensure patient safety and well-being.

In Aug 2024, Fresenius Medical Care (FME), a global leader in renal disease products and services, revealed FDA 510(k) clearance for its 5008X Hemodialysis System. With this milestone, FME aims to introduce a new standard of dialysis care to individuals with kidney diseases in the United States.

DaVita Inc.

In May 2022, DaVita Inc. and Medtronic plc revealed plans to establish a new independent medical device company dedicated to kidney care. This venture aims to elevate patient treatment experiences and enhance overall outcomes.

December 2022, DaVita served 200,000 patients at 2,724 US outpatient dialysis centers and 350 centers across 11 other countries. Their efforts reduced hospitalizations, enhanced mortality rates, and advocated for an equitable, high-quality standard of care in kidney treatment globally.

Medtronic Plc

In April 2023, DaVita and medical device company Medtronic inaugurated their collaborative endeavor, Mozarc Medical. This venture is dedicated to pioneering innovative kidney care technologies, mainly advancing at-home treatment options.

In Nov 2023, Medtronic plc disclosed FDA approval for the SymplicitySpyral™ renal denervation (RDN) system, also known as the Symplicity™ blood pressure procedure, to treat hypertension. With this clearance, Medtronic will promptly commence commercialization efforts.

In Aug 2023, Medtronic employees in Minnesota frequently collaborated with the National Kidney Foundation to aid kidney patients. This includes their involvement in the NKF's Drive for Dialysis program in June, offering a hands-on staff engagement to assemble dialysis care packages and engage with a dialysis patient's perspective.

Asahi Kasei Corporation

In December 2021, ExThera Medical and Asahi Kasei Medical signed a distribution deal in Japan for ExThera's Seraph Microbind Affinity Blood Filter to secure regulatory approval for Seraph 100's commercial launch in Japan.

Global Dialysis Market is predicted to grow at a CAGR of 5.56% throughout the forecast duration (2022-2028)

Two forms of dialysis exist: Peritoneal dialysis and hemodialysis. Waste materials which included urea are extracted greater corporeally from the patient's blood at some stage in hemodialysis. The peritoneum within the stomach is utilized for dialysis in peritoneal dialysis. The growth within the number of diabetic and hypertensive patients, the spike in financing for the improvement of recent drugs, and the upward thrust in the number of give up level renal ailment (ESRD) patients are all contributing to market growth. Furthermore, dialysis is desired over kidney transplantation that is projected to power dialysis market enlargement. Moreover, a growth in the older population, healthcare spending, and disposable income is expected to drive the dialysis market expansion.

As the global population is aging with time, the human beings with kidney failure are expected to increase. The market increase is attributed to the growth in variety of diabetic and high blood pressure patients, surge in investment for the development of latest merchandise, and an upward population of end stage renal disease (ESRD) patients. However, lack of understanding about kidney illnesses, product keep in mind, and discount in reimbursements for dialysis are expected to avoid the market boom. Global Dialysis Market Size was valued at US$ 102.09 Billion in 2022.

Hemodialysis market dominates the dialysis industry

By Type, Global Dialysis Market is segmented into peritoneal dialysis and Hemodialysis. Hemodialysis has the dominant market share in the dialysis industry. Renowned for its effectiveness in treating end-stage renal disorder (ESRD), this technique employs superior machines to successfully cleanse a patient's blood of waste and extra fluids. Its large accessibility through devoted facilities and hospitals contributes drastically to its prominence. With long-standing development and refinement of hemodialysis technology have engendered trust among healthcare providers and patients alike. Furthermore, the giant coverage it enjoys ensures its endured stronghold within the dialysis zone. While market dynamics can shift through the years, hemodialysis stays a cornerstone of renal alternative remedy.

Equipment is emerging because the fastest-developing segment within the dialysis industry

By Product & Services, Global Dialysis Market is divided into Services, Equipment, Consumables and Drugs. Equipment is experiencing amazing increase in the dialysis industry. This surge is attributed to ongoing technological improvements and the growing demand for contemporary dialysis machines and associated devices. These innovations are enhancing remedy precision, patient comfort, and typical performance. The dialysis device section is witnessing heightened investments and studies, ensuing in a numerous array of sophisticated gear designed to enhance the best of care for individuals with kidney-associated situations. As the industry keeps evolving, the speedy growth of dialysis devices highlights its pivotal role in revolutionizing renal cures, in the end promising better effects for patients and healthcare carriers inside the years to come.

In-center dialysis keeps holding a strong foothold market percentage in the dialysis industry.

By End User, Global Dialysis Market is classified into In-center dialysis and Home dialysis.  In-center dialysis maintains to preserve a dominant market in the dialysis industry. Renowned for its accessibility and comprehensive care, this modality thrives as a cornerstone in the treatment of end-level renal ailment (ESRD) and excessive kidney disorder. In committed dialysis centers or hospitals, patients benefit from professional supervision, rigorous monitoring, and the assurance of high-quality care. Furthermore, its massive recognition within insurance coverage policies makes it a desired significant patient demographic. While alternative opportunities like home dialysis are gaining traction, in-center dialysis remains the gold standard, underscoring its enduring importance and pivotal function in renal healthcare.

Healthy China 2030 objective is to improve the general health of the Chinese populace and growth in healthcare services

By Countries, Global Dialysis Market is split into United States, Argentina, Australia, Belgium, Brazil, Canada, China, France, Germany, India, Israel, Italy, Japan, Mexico, Netherland, Saudi Arabia, South Africa, Spain, Switzerland, United Kingdom, Turkey and Rest of World. The dialysis industry in China has witnessed vast increase and transformation in current years. With the rise in older population and a growing prevalence of persistent kidney ailment (CKD), the demand for renal alternative cures has surged. China's healthcare infrastructure has responded by expanding dialysis services and making an investment in advance system and technology. Public and personal partnerships have caused the status of numerous dialysis facilities across the country, enhancing accessibility for patients. The Chinese government has additionally been actively concerned in regulating and standardizing dialysis practices to ensure quality care. Furthermore, Chinese companies have made sizable strides in production dialysis device, contributing to domestic supply and global export. As the demand for renal care maintains to upward thrust, China's dialysis industry is poised for in addition enlargement and innovation.

Key Player

Baxter International Inc, Fresenius Medical Care, DaVita Inc., Medtronic Plc and Asahi Kasei Corporation are the primary companies operating within the global dialysis industry.

Type – Market has been covered from 2 viewpoints:

1.    Hemodialysis
2.    Peritoneal dialysis

Product & Services – Market has been covered from 4 viewpoints:

1.    Services
2.    Equipment
3.    Consumables
4.    Drugs

End-Users – Market has been covered from 2 viewpoints:

1.    In-center dialysis
2.    Home dialysis

Region – Market has been covered from 6 viewpoints:

1.    North America

1.1    United States
1.2    Canada

2.    Latin America

2.1    Argentina
2.2    Brazil
2.3    Mexico

3.    Europe

3.1    France
3.2    Germany
3.3    United Kingdom
3.4    Italy
3.5    Netherland
3.6    Spain
3.7    Switzerland
3.8    Belgium
3.9    Turkey

4.    Asia Pacific

4.1    China
4.2    India
4.3    Japan
4.4    Australia

5.    Middle East & Africa

5.1    Saudi-Arabia
5.2    Israel
5.3    South Africa

6.    Rest of the World

Company Insight:

•    Overview
•    Recent Development
•    Revenue

Company Covered:

1.    Baxter International Inc.
2.    Fresenius Medical Care
3.    DaVita Inc.
4.    Medtronic Plc
5.    Asahi Kasei Corporation

Report Details: